<DOC>
	<DOCNO>NCT00622817</DOCNO>
	<brief_summary>This randomize , double blind , control trial . The aim study compare xylometazoline HCL nasal drop inhalation epinephrine treatment bronchiolitis . The study hypothesis : xylometazoline HCL nasal drop treatment good epinephrine inhalation treatment bronchiolitis . Signed informed consent obtain parent child . And human ethic committee hospital approve study accord principle Declaration Helsinki . ( Approved - 2002 ) Patients : 65 infant admit Pediatric A- general pediatric ward , Schneider Children 's Medical Center bronchiolitis winter two consecutive year 2004-2005 . The inclusion criterion : Full term previously healthy Infants , age 1-12 month , inform consent sign clinical presentation mild moderate bronchiolitis accord clinical score .Exclusion criterion follow : prematurity , congenital lung cardiac disease , infant past hospitalization due respiratory illness severe bronchiolitis ( score &gt; 7 range scale 0-10 ) .</brief_summary>
	<brief_title>The Influence Inhaled Adrenalin Versus Decongestant Local Nasal Treatment Bronchiolitis</brief_title>
	<detailed_description>All eligible patient randomly assign one two group : Group 1 ( control ) receive inhalation epinephrine 1mg , 2cc 0.9 % saline solution four time day , nasal drop 0.9 % saline nostril every twelve hour . Group 2 - study group receive four inhalation 0.9 % saline four time day one nasal drop xylometazoline HCL nostril twice day . This treatment continue patient ready discharge . Patients examine evaluate study entry re-evaluated every 10-12 hour . Length hospital stay , time improve Oxygen saturation , time need IV fluid clinical score two group treatment compare .</detailed_description>
	<mesh_term>Bronchiolitis</mesh_term>
	<mesh_term>Nasal Decongestants</mesh_term>
	<mesh_term>Pseudoephedrine</mesh_term>
	<mesh_term>Xylometazoline</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>Full term previously healthy Infants Ages 112 month After informed consent sign clinical presentation mild moderate bronchiolitis Prematurity , congenital lung cardiac disease Infants past hospitalization due respiratory illness severe bronchiolitis ( score &gt; 7 range scale 010 )</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>12 Months</maximum_age>
	<verification_date>February 2002</verification_date>
	<keyword>Epinephrine</keyword>
	<keyword>Nasal decongestant</keyword>
	<keyword>RSV</keyword>
	<keyword>xylometazoline</keyword>
	<keyword>Bronchiolitis</keyword>
</DOC>